Literature DB >> 914819

Binding and biologic activity of glucagon in liver cell membranes of chronically hyperglucagonemic rats.

C B Srikant, D Freeman, K McCorkle, R H Unger.   

Abstract

Glucagon binding by liver cell membranes was examined in rats with chronically elevated plasma levels of immunoreactive glucagon (IRG) resulting from insulin deficiency, starvation, or twice daily glucagon injections. The concentration of specific glucagon binding sites was significantly reduced in the three chronically hyperglucagonemic (IRG greater than 125 pg/ml) groups as compared with nondiabetic controls and insulin-treated diabetic control rats with only mild hyperglucagonemia. A reduction in glucagon binding sites did not occur with hyperglucagonemia of 12 h or less. Despite the reduced binding of glucagon in the three chronically hyperglucagonemic groups, the ability of glucagon to stimulate cAMP production was not reduced. It is concluded that while decreased glucagon binding occures in the forms of chronic hyperglucagonemia studied, it is not associated with a reduction in the ability of glucagon to stimulate cAMP production.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 914819

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Changes in adenylate cyclase and 5-nucleotidase activities in liver membranes from alloxan diabetic rats.

Authors:  B Israelsson; I Tengrup
Journal:  Experientia       Date:  1980-02-15

2.  Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.

Authors:  A Francavilla; A F Jones; T E Starzl
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

3.  Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy.

Authors:  M B Anand-Srivastava; J H McNeill; X P Yang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

4.  High-fat diet-induced hepatic steatosis reduces glucagon receptor content in rat hepatocytes: potential interaction with acute exercise.

Authors:  Alexandre Charbonneau; Cecilia G Unson; Jean-Marc Lavoie
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

5.  Binding, internalization, and lysosomal association of 125I-glucagon in isolated rat hepatocytes. A quantitative electron microscope autoradiographic study.

Authors:  P Barazzone; P Gorden; J L Carpentier; L Orci; P Freychet; B Canivet
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

6.  Opposing effects of glucagon and triiodothyronine on the hepatic levels of messenger ribonucleic acid S14 and the dependence of such effects on circadian factors.

Authors:  W B Kinlaw; H L Schwartz; H C Towle; J H Oppenheimer
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

7.  Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.

Authors:  P Chatelain; P Robberecht; P De Neef; J C Camus; D Heuse; J Christophe
Journal:  Pflugers Arch       Date:  1980-12       Impact factor: 3.657

9.  Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.

Authors:  R Rizza; C Verdonk; J Miles; F J Service; J Gerich
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

10.  Regulatory effect of glucagon on its own receptor concentrations and target-cell sensitivity in the rat.

Authors:  A Santos; E Blazquez
Journal:  Diabetologia       Date:  1982-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.